751062
Last Update Posted: 2021-02-02
This data has been translated from it's original language using AI, and may contain errors. Please change your language to view the original data.
Recruiting has ended
All Genders accepted | 40 Years + |
267 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
En studie av åpenvinklet glaukom eller okulær hypertensjon hos pasienter i Skandinavia.
PhXA41 er ikke dårligere enn timolol i å redusere intraokulært trykk.
Eligibility
Relevant conditions:
Åpenvinklet glaukom
Øyesykdom
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov